STOCK TITAN

Calumet, Inc. (CLMT) director exercises 7,067 RSUs into common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Calumet, Inc. director Julio M. Quintana exercised restricted stock units into common stock. On July 9, 2026, he converted 7,067 restricted stock units into 7,067 shares of common stock, par value $0.01 per share. Following the transaction, he held 7,067 common shares directly. The restricted stock units, each economically equivalent to one share of common stock, had 100% vested on June 2, 2026.

Positive

  • None.

Negative

  • None.
Insider Quintana Julio M
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Unit 7,067 $0.00 --
Exercise Common Stock, par value $0.01 per share 7,067 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct); Common Stock, par value $0.01 per share — 7,067 shares (Direct)
Footnotes (1)
  1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. 100% of the Restricted Stock Units vested on June 2, 2026.
RSUs exercised 7,067 units Restricted stock units converted to common stock on July 9, 2026
Common shares acquired 7,067 shares Common Stock, par value $0.01 per share, received upon RSU conversion
Shares held after transaction 7,067 shares Direct ownership reported following the July 9, 2026 exercise
RSU vesting date June 2, 2026 100% of the restricted stock units vested on this date
Exercise price per share $0.0000 Reported transaction price per share for the RSU conversion
Restricted Stock Unit financial
"Security title reported as "Restricted Stock Unit" in the derivative transaction"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
economic equivalent financial
"Each Restricted Stock Unit is the economic equivalent of one share of common stock"
derivative exercise/conversion financial
"Transaction action described as derivative exercise/conversion for the RSUs"
par value $0.01 per share financial
"Common Stock, par value $0.01 per share received upon conversion"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Calumet, Inc. (CLMT) director Julio M. Quintana report in this Form 4?

Julio M. Quintana reported the exercise of 7,067 restricted stock units into 7,067 shares of Calumet, Inc. common stock. This reflects the settlement of vested equity awards into directly held shares.

How many Calumet, Inc. (CLMT) shares did Julio M. Quintana acquire?

Julio M. Quintana acquired 7,067 shares of Calumet, Inc. common stock. These shares resulted from the conversion of 7,067 restricted stock units that had previously been granted as equity compensation.

What type of securities did the Form 4 for Calumet, Inc. (CLMT) involve?

The Form 4 involved restricted stock units that were economically equivalent to Calumet, Inc. common stock, and their conversion into common stock, par value $0.01 per share, as part of director equity compensation.

When did the restricted stock units for Calumet, Inc. (CLMT) fully vest?

The restricted stock units 100% vested on June 2, 2026. After this vesting date, the units were eligible to be converted into shares of common stock, which occurred in the reported July 9, 2026 transaction.

How many Calumet, Inc. (CLMT) shares does Julio M. Quintana hold after the transaction?

After the transaction, Julio M. Quintana held 7,067 shares of Calumet, Inc. common stock directly. This reflects the full amount of 7,067 restricted stock units that were converted into common shares.

Was there any open-market buying or selling in this Calumet, Inc. (CLMT) Form 4?

No. The Form 4 shows a derivative exercise/conversion of restricted stock units into common stock, with no open-market purchases or sales reported and no tax-withholding dispositions indicated.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Quintana Julio M

(Last)(First)(Middle)
1060 N CAPITOL AVE
SUITE 6-401

(Street)
INDIANAPOLIS INDIANA 46204

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.01 per share07/09/2026M7,067A$07,067D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)07/09/2026M7,067 (2) (2)Common Stock, par value $0.01 per share7,067$00D
Explanation of Responses:
1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
2. 100% of the Restricted Stock Units vested on June 2, 2026.
Remarks:
/s/ Connor J. Egan, as attorney-in-fact07/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)